Neutrophil Gelatinase-Associated Lipocalin: Its Response to Hypoxia and Association with Acute Mountain Sickness

Acute Mountain Sickness (AMS) is a common clinical challenge at high altitude (HA). A point-of-care biochemical marker for AMS could have widespread utility. Neutrophil gelatinase-associated lipocalin (NGAL) rises in response to renal injury, inflammation and oxidative stress. We investigated whethe...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Disease markers 2013-01, Vol.2013 (2013), p.1-6
Hauptverfasser: King, Rod, Turner, Steve, Woods, David R., Piper, Rick, Yarker, Jo, Begley, Joe, Smith, Chris, Hooper, Tim, Stacey, Mike, Boos, Christopher, Mellor, Adrian, O'Hara, John
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 6
container_issue 2013
container_start_page 1
container_title Disease markers
container_volume 2013
creator King, Rod
Turner, Steve
Woods, David R.
Piper, Rick
Yarker, Jo
Begley, Joe
Smith, Chris
Hooper, Tim
Stacey, Mike
Boos, Christopher
Mellor, Adrian
O'Hara, John
description Acute Mountain Sickness (AMS) is a common clinical challenge at high altitude (HA). A point-of-care biochemical marker for AMS could have widespread utility. Neutrophil gelatinase-associated lipocalin (NGAL) rises in response to renal injury, inflammation and oxidative stress. We investigated whether NGAL rises with HA and if this rise was related to AMS, hypoxia or exercise. NGAL was assayed in a cohort (n=22) undertaking 6 hours exercise at near sea-level (SL); a cohort (n=14) during 3 hours of normobaric hypoxia (FiO2 11.6%) and on two trekking expeditions (n=52) to over 5000 m. NGAL did not change with exercise at SL or following normobaric hypoxia. During the trekking expeditions NGAL levels (ng/ml, mean ± sd, range) rose significantly (P
doi_str_mv 10.1155/2013/601214
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3817649</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1459160410</sourcerecordid><originalsourceid>FETCH-LOGICAL-c439t-3330cd8e5a2da40d8fe1598cc6284523140aea511e2d1790837932ed575454fe3</originalsourceid><addsrcrecordid>eNqN0U1v1DAQBmALgei2cOKOfESgUH8mNgekVQVtpQUkPs7WYE9YQ9YOsUPbf0-qbaty4-TDPPOOpZeQZ5y95lzrY8G4PG4ZF1w9ICtuOt2YVrKHZMVEZxomFDsgh6X8ZIuxyj4mB0KJZWTFiowfca5THrdxoKc4QI0JCjbrUrKPUDHQTRyzhyGmN_S8FvoZy5hTQVozPbsa82UECinQ242YE72IdUvXfq5IP-Q5VYiJfon-V8JSnpBHPQwFn968R-Tb-3dfT86azafT85P1pvFK2tpIKZkPBjWIAIoF0yPX1njfCqO0kFwxQNCcowi8s8zIzkqBQXdaadWjPCJv97nj_H2HwWOqEwxunOIOpiuXIbp_Jylu3Y_8x0nDu1bZJeDFTcCUf89YqtvF4nEYIGGei-NKW94yxdlCX-2pn3IpE_Z3Zzhz1x25647cvqNFP7__szt7W8oCXu7BNqYAF_H_0nAh2MM9LBfA5F8bcqQ2</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1459160410</pqid></control><display><type>article</type><title>Neutrophil Gelatinase-Associated Lipocalin: Its Response to Hypoxia and Association with Acute Mountain Sickness</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Wiley Online Library (Open Access Collection)</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>King, Rod ; Turner, Steve ; Woods, David R. ; Piper, Rick ; Yarker, Jo ; Begley, Joe ; Smith, Chris ; Hooper, Tim ; Stacey, Mike ; Boos, Christopher ; Mellor, Adrian ; O'Hara, John</creator><contributor>Lapaire, Olav</contributor><creatorcontrib>King, Rod ; Turner, Steve ; Woods, David R. ; Piper, Rick ; Yarker, Jo ; Begley, Joe ; Smith, Chris ; Hooper, Tim ; Stacey, Mike ; Boos, Christopher ; Mellor, Adrian ; O'Hara, John ; Lapaire, Olav</creatorcontrib><description>Acute Mountain Sickness (AMS) is a common clinical challenge at high altitude (HA). A point-of-care biochemical marker for AMS could have widespread utility. Neutrophil gelatinase-associated lipocalin (NGAL) rises in response to renal injury, inflammation and oxidative stress. We investigated whether NGAL rises with HA and if this rise was related to AMS, hypoxia or exercise. NGAL was assayed in a cohort (n=22) undertaking 6 hours exercise at near sea-level (SL); a cohort (n=14) during 3 hours of normobaric hypoxia (FiO2 11.6%) and on two trekking expeditions (n=52) to over 5000 m. NGAL did not change with exercise at SL or following normobaric hypoxia. During the trekking expeditions NGAL levels (ng/ml, mean ± sd, range) rose significantly (P&lt;0.001) from 68 ± 14 (60–102) at 1300 m to 183 ± 107 (65–519); 143 ± 66 (60–315) and 150 ± 71 (60–357) at 3400 m, 4270 m and 5150 m respectively. At 5150 m there was a significant difference in NGAL between those with severe AMS (n=7), mild AMS (n=16) or no AMS (n=23): 201 ± 34 versus 171 ± 19 versus 124 ± 12 respectively (P=0.009 for severe versus no AMS; P=0.026 for mild versus no AMS). In summary, NGAL rises in response to prolonged hypobaric hypoxia and demonstrates a relationship to the presence and severity of AMS.</description><identifier>ISSN: 0278-0240</identifier><identifier>EISSN: 1875-8630</identifier><identifier>DOI: 10.1155/2013/601214</identifier><identifier>PMID: 24227892</identifier><language>eng</language><publisher>Cairo, Egypt: Hindawi Publishing Corporation</publisher><subject>Acute-Phase Proteins ; Adult ; Altitude ; Altitude Sickness - blood ; Altitude Sickness - diagnosis ; Biomarkers - blood ; Case-Control Studies ; Clinical Study ; Exercise ; Female ; Humans ; Hypoxia - blood ; Lipocalin-2 ; Lipocalins - blood ; Male ; Proto-Oncogene Proteins - blood</subject><ispartof>Disease markers, 2013-01, Vol.2013 (2013), p.1-6</ispartof><rights>Copyright © 2013 Adrian Mellor et al.</rights><rights>Copyright © 2013 Adrian Mellor et al. 2013</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c439t-3330cd8e5a2da40d8fe1598cc6284523140aea511e2d1790837932ed575454fe3</citedby><cites>FETCH-LOGICAL-c439t-3330cd8e5a2da40d8fe1598cc6284523140aea511e2d1790837932ed575454fe3</cites><orcidid>0000-0002-4971-3939 ; 0000-0002-9061-5177</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3817649/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3817649/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,315,728,781,785,886,27929,27930,53796,53798</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24227892$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Lapaire, Olav</contributor><creatorcontrib>King, Rod</creatorcontrib><creatorcontrib>Turner, Steve</creatorcontrib><creatorcontrib>Woods, David R.</creatorcontrib><creatorcontrib>Piper, Rick</creatorcontrib><creatorcontrib>Yarker, Jo</creatorcontrib><creatorcontrib>Begley, Joe</creatorcontrib><creatorcontrib>Smith, Chris</creatorcontrib><creatorcontrib>Hooper, Tim</creatorcontrib><creatorcontrib>Stacey, Mike</creatorcontrib><creatorcontrib>Boos, Christopher</creatorcontrib><creatorcontrib>Mellor, Adrian</creatorcontrib><creatorcontrib>O'Hara, John</creatorcontrib><title>Neutrophil Gelatinase-Associated Lipocalin: Its Response to Hypoxia and Association with Acute Mountain Sickness</title><title>Disease markers</title><addtitle>Dis Markers</addtitle><description>Acute Mountain Sickness (AMS) is a common clinical challenge at high altitude (HA). A point-of-care biochemical marker for AMS could have widespread utility. Neutrophil gelatinase-associated lipocalin (NGAL) rises in response to renal injury, inflammation and oxidative stress. We investigated whether NGAL rises with HA and if this rise was related to AMS, hypoxia or exercise. NGAL was assayed in a cohort (n=22) undertaking 6 hours exercise at near sea-level (SL); a cohort (n=14) during 3 hours of normobaric hypoxia (FiO2 11.6%) and on two trekking expeditions (n=52) to over 5000 m. NGAL did not change with exercise at SL or following normobaric hypoxia. During the trekking expeditions NGAL levels (ng/ml, mean ± sd, range) rose significantly (P&lt;0.001) from 68 ± 14 (60–102) at 1300 m to 183 ± 107 (65–519); 143 ± 66 (60–315) and 150 ± 71 (60–357) at 3400 m, 4270 m and 5150 m respectively. At 5150 m there was a significant difference in NGAL between those with severe AMS (n=7), mild AMS (n=16) or no AMS (n=23): 201 ± 34 versus 171 ± 19 versus 124 ± 12 respectively (P=0.009 for severe versus no AMS; P=0.026 for mild versus no AMS). In summary, NGAL rises in response to prolonged hypobaric hypoxia and demonstrates a relationship to the presence and severity of AMS.</description><subject>Acute-Phase Proteins</subject><subject>Adult</subject><subject>Altitude</subject><subject>Altitude Sickness - blood</subject><subject>Altitude Sickness - diagnosis</subject><subject>Biomarkers - blood</subject><subject>Case-Control Studies</subject><subject>Clinical Study</subject><subject>Exercise</subject><subject>Female</subject><subject>Humans</subject><subject>Hypoxia - blood</subject><subject>Lipocalin-2</subject><subject>Lipocalins - blood</subject><subject>Male</subject><subject>Proto-Oncogene Proteins - blood</subject><issn>0278-0240</issn><issn>1875-8630</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>RHX</sourceid><sourceid>EIF</sourceid><recordid>eNqN0U1v1DAQBmALgei2cOKOfESgUH8mNgekVQVtpQUkPs7WYE9YQ9YOsUPbf0-qbaty4-TDPPOOpZeQZ5y95lzrY8G4PG4ZF1w9ICtuOt2YVrKHZMVEZxomFDsgh6X8ZIuxyj4mB0KJZWTFiowfca5THrdxoKc4QI0JCjbrUrKPUDHQTRyzhyGmN_S8FvoZy5hTQVozPbsa82UECinQ242YE72IdUvXfq5IP-Q5VYiJfon-V8JSnpBHPQwFn968R-Tb-3dfT86azafT85P1pvFK2tpIKZkPBjWIAIoF0yPX1njfCqO0kFwxQNCcowi8s8zIzkqBQXdaadWjPCJv97nj_H2HwWOqEwxunOIOpiuXIbp_Jylu3Y_8x0nDu1bZJeDFTcCUf89YqtvF4nEYIGGei-NKW94yxdlCX-2pn3IpE_Z3Zzhz1x25647cvqNFP7__szt7W8oCXu7BNqYAF_H_0nAh2MM9LBfA5F8bcqQ2</recordid><startdate>20130101</startdate><enddate>20130101</enddate><creator>King, Rod</creator><creator>Turner, Steve</creator><creator>Woods, David R.</creator><creator>Piper, Rick</creator><creator>Yarker, Jo</creator><creator>Begley, Joe</creator><creator>Smith, Chris</creator><creator>Hooper, Tim</creator><creator>Stacey, Mike</creator><creator>Boos, Christopher</creator><creator>Mellor, Adrian</creator><creator>O'Hara, John</creator><general>Hindawi Publishing Corporation</general><scope>ADJCN</scope><scope>AHFXO</scope><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-4971-3939</orcidid><orcidid>https://orcid.org/0000-0002-9061-5177</orcidid></search><sort><creationdate>20130101</creationdate><title>Neutrophil Gelatinase-Associated Lipocalin: Its Response to Hypoxia and Association with Acute Mountain Sickness</title><author>King, Rod ; Turner, Steve ; Woods, David R. ; Piper, Rick ; Yarker, Jo ; Begley, Joe ; Smith, Chris ; Hooper, Tim ; Stacey, Mike ; Boos, Christopher ; Mellor, Adrian ; O'Hara, John</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c439t-3330cd8e5a2da40d8fe1598cc6284523140aea511e2d1790837932ed575454fe3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Acute-Phase Proteins</topic><topic>Adult</topic><topic>Altitude</topic><topic>Altitude Sickness - blood</topic><topic>Altitude Sickness - diagnosis</topic><topic>Biomarkers - blood</topic><topic>Case-Control Studies</topic><topic>Clinical Study</topic><topic>Exercise</topic><topic>Female</topic><topic>Humans</topic><topic>Hypoxia - blood</topic><topic>Lipocalin-2</topic><topic>Lipocalins - blood</topic><topic>Male</topic><topic>Proto-Oncogene Proteins - blood</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>King, Rod</creatorcontrib><creatorcontrib>Turner, Steve</creatorcontrib><creatorcontrib>Woods, David R.</creatorcontrib><creatorcontrib>Piper, Rick</creatorcontrib><creatorcontrib>Yarker, Jo</creatorcontrib><creatorcontrib>Begley, Joe</creatorcontrib><creatorcontrib>Smith, Chris</creatorcontrib><creatorcontrib>Hooper, Tim</creatorcontrib><creatorcontrib>Stacey, Mike</creatorcontrib><creatorcontrib>Boos, Christopher</creatorcontrib><creatorcontrib>Mellor, Adrian</creatorcontrib><creatorcontrib>O'Hara, John</creatorcontrib><collection>الدوريات العلمية والإحصائية - e-Marefa Academic and Statistical Periodicals</collection><collection>معرفة - المحتوى العربي الأكاديمي المتكامل - e-Marefa Academic Complete</collection><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Disease markers</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>King, Rod</au><au>Turner, Steve</au><au>Woods, David R.</au><au>Piper, Rick</au><au>Yarker, Jo</au><au>Begley, Joe</au><au>Smith, Chris</au><au>Hooper, Tim</au><au>Stacey, Mike</au><au>Boos, Christopher</au><au>Mellor, Adrian</au><au>O'Hara, John</au><au>Lapaire, Olav</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Neutrophil Gelatinase-Associated Lipocalin: Its Response to Hypoxia and Association with Acute Mountain Sickness</atitle><jtitle>Disease markers</jtitle><addtitle>Dis Markers</addtitle><date>2013-01-01</date><risdate>2013</risdate><volume>2013</volume><issue>2013</issue><spage>1</spage><epage>6</epage><pages>1-6</pages><issn>0278-0240</issn><eissn>1875-8630</eissn><abstract>Acute Mountain Sickness (AMS) is a common clinical challenge at high altitude (HA). A point-of-care biochemical marker for AMS could have widespread utility. Neutrophil gelatinase-associated lipocalin (NGAL) rises in response to renal injury, inflammation and oxidative stress. We investigated whether NGAL rises with HA and if this rise was related to AMS, hypoxia or exercise. NGAL was assayed in a cohort (n=22) undertaking 6 hours exercise at near sea-level (SL); a cohort (n=14) during 3 hours of normobaric hypoxia (FiO2 11.6%) and on two trekking expeditions (n=52) to over 5000 m. NGAL did not change with exercise at SL or following normobaric hypoxia. During the trekking expeditions NGAL levels (ng/ml, mean ± sd, range) rose significantly (P&lt;0.001) from 68 ± 14 (60–102) at 1300 m to 183 ± 107 (65–519); 143 ± 66 (60–315) and 150 ± 71 (60–357) at 3400 m, 4270 m and 5150 m respectively. At 5150 m there was a significant difference in NGAL between those with severe AMS (n=7), mild AMS (n=16) or no AMS (n=23): 201 ± 34 versus 171 ± 19 versus 124 ± 12 respectively (P=0.009 for severe versus no AMS; P=0.026 for mild versus no AMS). In summary, NGAL rises in response to prolonged hypobaric hypoxia and demonstrates a relationship to the presence and severity of AMS.</abstract><cop>Cairo, Egypt</cop><pub>Hindawi Publishing Corporation</pub><pmid>24227892</pmid><doi>10.1155/2013/601214</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0002-4971-3939</orcidid><orcidid>https://orcid.org/0000-0002-9061-5177</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0278-0240
ispartof Disease markers, 2013-01, Vol.2013 (2013), p.1-6
issn 0278-0240
1875-8630
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3817649
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Wiley Online Library (Open Access Collection); PubMed Central; Alma/SFX Local Collection
subjects Acute-Phase Proteins
Adult
Altitude
Altitude Sickness - blood
Altitude Sickness - diagnosis
Biomarkers - blood
Case-Control Studies
Clinical Study
Exercise
Female
Humans
Hypoxia - blood
Lipocalin-2
Lipocalins - blood
Male
Proto-Oncogene Proteins - blood
title Neutrophil Gelatinase-Associated Lipocalin: Its Response to Hypoxia and Association with Acute Mountain Sickness
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-14T09%3A59%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Neutrophil%20Gelatinase-Associated%20Lipocalin:%20Its%20Response%20to%20Hypoxia%20and%20Association%20with%20Acute%20Mountain%20Sickness&rft.jtitle=Disease%20markers&rft.au=King,%20Rod&rft.date=2013-01-01&rft.volume=2013&rft.issue=2013&rft.spage=1&rft.epage=6&rft.pages=1-6&rft.issn=0278-0240&rft.eissn=1875-8630&rft_id=info:doi/10.1155/2013/601214&rft_dat=%3Cproquest_pubme%3E1459160410%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1459160410&rft_id=info:pmid/24227892&rfr_iscdi=true